Why Employers Still Skip Full GLP-1 Obesity Drug Coverage and What’s Changing (2026 Guide)
Discover why many U.S. employers still skip GLP-1 obesity drug coverage and how new regulations and cost trends are finally shifting benefits decisions.
FDA selects Lilly, Regeneron for fast-track facility reviews
The FDA fast-track PreCheck pilot selects Lilly and Regeneron for accelerated reviews of new domestic manufacturing facilities, potentially…
Why Employers Still Skip Full GLP-1 Obesity Drug Coverage and What’s Changing (2026 Guide)
Discover why many U.S. employers still skip GLP-1 obesity drug coverage and how new regulations and cost trends…
Klarna Pursues U.S. Bank Charter to Expand Services
Klarna bank charter could let the fintech launch a U.S. bank, expanding its buy‑now‑pay‑later service into traditional banking…
US and Iran begin talks amid Hormuz dispute
US and Iran begin high-stakes talks amid the Hormuz dispute over the Strait of Hormuz, a critical oil…
Record Steak Prices Persist Despite High Costs
Americans face record steak prices this Fourth of July despite high costs. Discover why demand remains strong and…